AAAAAA

   
Results: 1-11 |
Results: 11
POTENTIATION OF 2-CHLORODEOXYADENOSINE ACTIVITY BY BRYOSTATIN-1 IN THE RESISTANT CHRONIC LYMPHOCYTIC-LEUKEMIA CELL-LINE (WSU-CLL) - ASSOCIATION WITH INCREASED RATIOS OF DCK 5'-NT AND BAX/BCL-2/
Authors: MOHAMMAD RM BECK FWJ KATATO K HAMDY N WALL N ALKATIB A
Citation: Rm. Mohammad et al., POTENTIATION OF 2-CHLORODEOXYADENOSINE ACTIVITY BY BRYOSTATIN-1 IN THE RESISTANT CHRONIC LYMPHOCYTIC-LEUKEMIA CELL-LINE (WSU-CLL) - ASSOCIATION WITH INCREASED RATIOS OF DCK 5'-NT AND BAX/BCL-2/, Biological chemistry, 379(10), 1998, pp. 1253-1261
SEQUENTIAL TREATMENT OF HUMAN CHRONIC LYMPHOCYTIC-LEUKEMIA WITH BRYOSTATIN-1 FOLLOWED BY 2-CHLORODEOXYADENOSINE - PRECLINICAL STUDIES
Authors: MOHAMMAD RM KATATO K ALMATCHY VP WALL N LIU KZ SCHULTZ CP MANTSCH HH VARTERASIAN M ALKATIB AM
Citation: Rm. Mohammad et al., SEQUENTIAL TREATMENT OF HUMAN CHRONIC LYMPHOCYTIC-LEUKEMIA WITH BRYOSTATIN-1 FOLLOWED BY 2-CHLORODEOXYADENOSINE - PRECLINICAL STUDIES, Clinical cancer research, 4(2), 1998, pp. 445-453
SEQUENTIAL TREATMENT OF HUMAN CHRONIC LYMPHOCYTIC-LEUKEMIA WITH BRYOSTATIN-1 FOLLOWED BY 2-CHLORODEOXYADENOSINE - PRECLINICAL STUDIES
Authors: MOHAMMAD RM KATATO K ALMATCHY VP WALL N LIU KZ SCHULTZ CP MANTSCH HH VARTERASIAN M ALKATIB AM
Citation: Rm. Mohammad et al., SEQUENTIAL TREATMENT OF HUMAN CHRONIC LYMPHOCYTIC-LEUKEMIA WITH BRYOSTATIN-1 FOLLOWED BY 2-CHLORODEOXYADENOSINE - PRECLINICAL STUDIES, Clinical cancer research, 4(2), 1998, pp. 445-453
SYNERGISTIC INTERACTION OF SELECTED MARINE ANIMAL ANTICANCER DRUGS AGAINST HUMAN DIFFUSE LARGE-CELL LYMPHOMA
Authors: MOHAMMAD RM PETTIT GR ALMATCHY VP WALL N VARTERASIAN M ALKATIB A
Citation: Rm. Mohammad et al., SYNERGISTIC INTERACTION OF SELECTED MARINE ANIMAL ANTICANCER DRUGS AGAINST HUMAN DIFFUSE LARGE-CELL LYMPHOMA, Anti-cancer drugs, 9(2), 1998, pp. 149-156
GENISTEIN-INDUCED G(2)-M ARREST, P21(WAF1) UP-REGULATION, AND APOPTOSIS IN A NON-SMALL-CELL LUNG-CANCER CELL-LINE
Authors: LIAN FR BHUIYAN M LI YW WALL N KRAUT M SARKAR FH
Citation: Fr. Lian et al., GENISTEIN-INDUCED G(2)-M ARREST, P21(WAF1) UP-REGULATION, AND APOPTOSIS IN A NON-SMALL-CELL LUNG-CANCER CELL-LINE, Nutrition and cancer, 31(3), 1998, pp. 184-191
A NEW TUBULIN POLYMERIZATION INHIBITOR, AURISTATIN PE, DOWN-REGULATESALTERED P53 AND INDUCES TUMOR-REGRESSION IN A HUMAN WALDENSTROMS MACROGLOBULINEMIA MODEL
Authors: LIMVARAPUSS C MOHAMMAD RM WALL N HAMDY N MEHRA V PETTIT GR ALKATIB A
Citation: C. Limvarapuss et al., A NEW TUBULIN POLYMERIZATION INHIBITOR, AURISTATIN PE, DOWN-REGULATESALTERED P53 AND INDUCES TUMOR-REGRESSION IN A HUMAN WALDENSTROMS MACROGLOBULINEMIA MODEL, Blood, 90(10), 1997, pp. 1458-1458
THE ROLE OF BRYOSTATIN-1 IN 2-CDA RESISTANT B-CLL LINE - MECHANISM OFRESISTANCE AND RESPONSE
Authors: MOHAMMAD RM BECK FWJ WALL N HAMDY N MENDPARA SD LIU KZ SCHULTZ CP HANNOUDI GN MANTSCH HH ALKATIB A
Citation: Rm. Mohammad et al., THE ROLE OF BRYOSTATIN-1 IN 2-CDA RESISTANT B-CLL LINE - MECHANISM OFRESISTANCE AND RESPONSE, Blood, 90(10), 1997, pp. 2364-2364
JUDICIAL ATTITUDES TO EXPERT EVIDENCE IN CHILDRENS CASES
Authors: WALL N
Citation: N. Wall, JUDICIAL ATTITUDES TO EXPERT EVIDENCE IN CHILDRENS CASES, Archives of Disease in Childhood, 76(6), 1997, pp. 485-487
BONE MORPHOGENETIC PROTEIN-6 EXPRESSION IN NORMAL AND MALIGNANT PROSTATE
Authors: BARNES J ANTHONY CT WALL N STEINER MS
Citation: J. Barnes et al., BONE MORPHOGENETIC PROTEIN-6 EXPRESSION IN NORMAL AND MALIGNANT PROSTATE, World journal of urology, 13(6), 1995, pp. 337-343
GLOBAL SYSTEM FOR MOBILE COMMUNICATIONS - THE DEVELOPMENT OF THE GSM STANDARD
Authors: ADAMS PM WALL N
Citation: Pm. Adams et N. Wall, GLOBAL SYSTEM FOR MOBILE COMMUNICATIONS - THE DEVELOPMENT OF THE GSM STANDARD, British telecommunications engineering, 14, 1995, pp. 38-45
COMMUNICATIONS ON THE MOVE
Authors: WALL N GROVES I
Citation: N. Wall et I. Groves, COMMUNICATIONS ON THE MOVE, British telecommunications engineering, 13, 1995, pp. 267-267
Risultati: 1-11 |